Saranas Submits De Novo Application to FDA for the Early BirdTM Bleed Monitoring System

4/24/18: “This is an important milestone for Saranas as it illustrates the ability of our team to execute on our development and regulatory strategies,” said President and CEO Zaffer Syed.

Saranas Invited to Present at CRT18 in Washington, DC

3/2/18: Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, has been invited to present at the 21st Cardiovascular Research Technologies (CRT18) annual conference, March 6, 2018, in Washington, DC.

angelMD Completes Investment in Bleeding Detection Medical Device Company

angelMD announced the closure of a new syndicate investment in Saranas, a promising new medical device startup. Dan Parsley, angelMD’s SVP of Corporate Development, served as the syndicate leader for this first investment in Saranas by angelMD...